Andersson M L, Vennström B
Department of Cell and Molecular Biology, Karolinska Institute, Stockholm, Sweden.
Oncogene. 2000 Jul 27;19(32):3563-9. doi: 10.1038/sj.onc.1203692.
The v-erbA oncoprotein (P75gag-v-erbA) can repress thyroid hormone receptor induced transcriptional activation of target genes. A central question is how hormone responsive elements in a target gene determine the transcriptional regulation mediated by P75gag-v-erbA. We addressed this with receptors chimeric between P75gag-v-erbA and thyroid hormone receptor (TR) by testing their regulatory activities on thyroid hormone response elements (TREs) differing in the sequence of the consensus core recognition motif AGGTCA. We report here that enhances, TR dependent transcriptional activation is conferred by P75gag-v-erbA when the thymidine in the half site recognition motif is exchanged for an adenosine. The enhancement was independent of the DNA binding region of P75gag-v-erbA, whereas increased expression of corepressor abolished the enhancing effect. The data indicate that the enhancement results from an impaired DNA binding by the oncoprotein combined with an effective scavenging of corepressors. Our data thus suggest the P75gag-v-erbA indirectly can contribute to enhancement of thyroid hormone induced gene expression.
v-erbA癌蛋白(P75gag-v-erbA)可抑制甲状腺激素受体诱导的靶基因转录激活。一个核心问题是靶基因中的激素反应元件如何决定由P75gag-v-erbA介导的转录调控。我们通过测试P75gag-v-erbA与甲状腺激素受体(TR)之间的嵌合受体对共有核心识别基序AGGTCA序列不同的甲状腺激素反应元件(TREs)的调控活性来解决这个问题。我们在此报告,当半位点识别基序中的胸腺嘧啶被腺嘌呤替换时,P75gag-v-erbA可赋予TR依赖性转录激活增强作用。这种增强作用与P75gag-v-erbA的DNA结合区域无关,而共抑制因子表达的增加消除了这种增强作用。数据表明,这种增强作用是由于癌蛋白的DNA结合受损以及共抑制因子的有效清除所致。因此,我们的数据表明P75gag-v-erbA可间接促进甲状腺激素诱导的基因表达增强。